Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

UChicago study reveals high doses of radiation can cause growth in existing metastatic tumors

Researchers at the University of Chicago Medicine Comprehensive Cancer Center have discovered that high doses of radiation cause growth in existing metastatic tumors that weren’t directly treated with radiation.
May 16, 2025
Vol.51 No.19
Trump administration is removing the mainstays of NCI and the federal government’s cancer program

Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit

How is the enterprise of cancer research doing after the first 100 days of the Trump administration?
May 09, 2025
Vol.51 No.18
By Paul Goldberg and Jacquelyn Cobb
In Brief

Indonesia, CRUK Scotland Institute partner to advance cancer research

The Ministry of Health of the Republic of Indonesia and the CRUK Scotland Institute entered into a partnership to advance cancer research, build capacity in cancer care, and support evidence-based health policies.
May 09, 2025
Vol.51 No.18
Clinical Roundup

Zinc-transporting protein contributes to aggressive growth of brain tumor, study shows

University of Oklahoma researchers have discovered one reason why the brain tumor glioblastoma is so aggressive.
May 09, 2025
Vol.51 No.18
NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Capitol Hill

NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing

In the starkest opposition yet by Republicans to the Trump administration’s attacks on HHS agencies, senators from both parties sounded an alarm about the damage being done to biomedical research in the U.S. 
May 02, 2025
Vol.51 No.17
By Claire Marie Porter
In Brief

UVA Health opens expanded Cancer Infusion Center, clinic at Pantops

UVA Health opened an expanded cancer infusion and clinic space at Pantops in Albemarle County. 
May 02, 2025
Vol.51 No.17
Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI
Sponsored

Ci4CC’s 23rd Cancer Center Summit to focus on accelerating oncology innovation through AI

We are at a transformational period in oncology; the overall mortality from cancer is gradually declining in the United States. 
April 25, 2025
Vol.51 No.16
By Suresh S. Ramalingam and Adam Marcus
Advancing peritoneal oncology: Innovations in surgical strategies and research
Sponsored

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options. 
April 25, 2025
Vol.51 No.16
By Mustafa Raoof
Cancer Policy

NSF director Sethuraman Panchanathan to resign

Sethuraman Panchanathan, director of the National Science Foundation, will resign from the position 16 months before the scheduled end of his six-year term. 
April 25, 2025
Vol.51 No.16
By Jacquelyn Cobb and Claire Marie Porter
William Hait named AACR chief scientific advisor
In Brief

William Hait named AACR chief scientific advisor

William N. Hait was named as chief scientific advisor to the American Association for Cancer Research.
April 25, 2025
Vol.51 No.16

Posts navigation

Previous1…345…12Next

Trending Stories

  • The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
  • NIH eliminates the NCI Board of Scientific Advisors
    Over its 28 year history, BSA shaped NCI-funded extramural science
  • In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
  • George Sigounas named the first-ever chief science advisor at NCI
  • The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
    Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”
  • Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account